AUTL - Autolus Therapeutics GAAP EPS of -$0.23 beats by $0.04
2023-05-04 07:25:53 ET
- Autolus Therapeutics press release ( NASDAQ: AUTL ): Q1 GAAP EPS of -$0.23 beats by $0.04 .
- Cash and cash equivalents and restricted cash at March 31, 2023, totaled $343.4 million, as compared to cash of $382.8 million at December 31, 2022.
For further details see:
Autolus Therapeutics GAAP EPS of -$0.23 beats by $0.04